title: Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Bastard
authors.forename: Claire
authors.initials: C
authors.lastname: Lagathu
authors.forename: Martine
authors.initials: M
authors.lastname: Caron
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Capeau
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D005947:Glucose / Q000378:metabolism*; D006706:Homeostasis / Q000502:physiology*; D006801:Humans; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance / Q000502:physiology*; D015850:Interleukin-6 / Q000235:genetics / Q000502:physiology*; D008099:Liver / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
chemical_list: D007328:Insulin; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D005947:Glucose